Shift Labs, the medical technology company founded by Human Centered Design & Engineering Professor Beth Kolko, has announced a new partnership with Hometa.
The partnership between Shift Labs and Hometa will enable the company to distribute its DripAssist Infusion Rate Monitor to a significantly larger audience.
DripAssist is a simple and affordable infusion rate monitor that provides precise flow rate and volume monitoring for IV medication management. Kolko and her team at Shift Labs have spent the last eight years working on the ground with health providers—ranging from maternal care workers in Kenya, Ebola responders in the Democratic Republic of Congo, to COVID-19 responders in New Jersey—to design medical devices that meet their needs and are easy to use.
"When we started building devices with an eye to great human-centered design and the belief that Simple Saves Lives, we had emerging markets in mind; to our surprise, we discovered that healthcare practitioners in the US, Europe, and elsewhere were also enthusiastic about this approach," Kolko wrote in a blog post announcing the partnership. "We've learned that when you build something that is simple to use, priced affordably, and that lasts a long time—it appeals to customers everywhere."
Hometa will begin taking over DripAssist manufacturing and commercialization for North and South America. The Shift Labs team will continue focusing on new innovations using human-centered design to increase healthcare equity on a global scale.
Read the press release on the Shift Labs website.